Clinical Trials Browser

Completed × TLC 388 × Clear all

NCT00747474 2019-11-18

Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors

Phase 1 Completed

54 enrolled 30 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02457273 2019-04-03

Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients

Phase 2 Completed

Carcinoma, Neuroendocrine